Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes

    ... MDS patients underwent UCBT as reported to the Center for International Blood and Marrow Transplant Research. Median age at the time of ... 19% high, and 13% very high-risk Revised International Prognostic Scoring System (IPSS-R) scores, respectively. The 100-day ...

    Research Article last updated 03/22/2017 - 9:24am.

  2. Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional

    ... PURPOSEThe definition of disease-specific prognostic scores plays a fundamental role in the treatment decision-making ... AND METHODSWe applied the recently published Revised International Prognostic Scoring System (IPSS-R) to 380 patients with MDS, ...

    Research Article last updated 08/07/2013 - 9:18am.

  3. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes

    ... forms the cornerstone of the most widely adopted prognostic scoring systems in MDS, the international prognostic scoring system (IPSS) and the revised ...

    Research Article last updated 01/26/2017 - 11:01am.

  4. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.

    ... 2 superiority trial of adult patients with low-risk or International Prognostic Scoring System intermediate-1-risk myelodysplastic syndromes and ...

    Research Article last updated 02/21/2017 - 9:49am.

  5. The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system

    ... (MDS) is currently estimated by using the revised International Prognostic Scoring System (IPSS-R). Several studies have shown that ...

    Research Article last updated 12/08/2015 - 1:08pm.

  6. Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index

    ... clinical outcome. For improved risk stratification, the International Prognostic Scoring System (IPSS) has recently been revised (IPSS-R). This ...

    Research Article last updated 01/20/2015 - 1:12pm.

  7. Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher risk myelodysplastic syndromes

    ... and pracinostat was conducted in patients who had International Prognostic Scoring System intermediate-2-risk or high-risk MDS. The primary ...

    Research Article last updated 02/03/2017 - 11:12am.

  8. Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes

    ... In patients classified according to the Revised International Prognostic Scoring System (R-IPSS) with intermediate or higher-risk disease, there is ...

    Research Article last updated 02/01/2017 - 8:17am.

  9. Treatment of low-risk myelodysplastic syndromes

    ... of myelodysplastic syndrome (MDS) patients belong to the International Prognostic Scoring System (IPSS) and IPSS-revised (IPSS-R) lower-risk ...

    Research Article last updated 01/26/2017 - 10:42am.

  10. Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes.

    ... intermediate-risk disease as classified by the Revised International Prognostic Scoring System (IPSS-R) or those with higher-risk disease for ...

    Research Article last updated 01/24/2017 - 7:25am.